Cagrilintide research peptide
CAS 1415456-99-3 · 4409 g/mol · also supplied as API
long-acting amylin analogue. Investigational; in clinical development and not yet approved by the FDA, EMA or other major regulators. Used only in pharmaceutical R&D and as a reference standard.










